Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures


Creative Commons License

Kurt M., Onal I. K., Akdogan M., KEKİLLİ M., Arhan M., Sayilir A., ...More

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol.24, no.6, pp.380-384, 2010 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 6
  • Publication Date: 2010
  • Doi Number: 10.1155/2010/896819
  • Journal Name: CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.380-384
  • Keywords: Ankaferd Blood Stopper, Bleeding, Dieulafoy's lesion, Mallory-Weiss tear, Polypectomy, Radiation colitis, MALLORY-WEISS-SYNDROME, ANTRAL VASCULAR ECTASIA, COMPLICATION, EFFICACY, ULCER, MODEL
  • Gazi University Affiliated: No

Abstract

OBJECTIVE: To assess the hemostatic efficacy of the Ankaferd Blood Stopper (ABS, Ankaferd Health Products Ltd, Turkey) hemostatic agent for controlling gastrointestinal bleeding associated with various benign lesions refractory to conventional antihemorrhagic measures.